U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Protein
Created
by admin
on Sat Dec 16 00:21:49 GMT 2023
Edited
by admin
on Sat Dec 16 00:21:49 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
G88KCP51RE
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
APOLIZUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
Apolizumab [WHO-DD]
Common Name English
HU1D10
Code English
REMITOGEN
Brand Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN HISTOCOMPATIBILITY ANTIGEN HLA-DR) (HUMAN-MOUSE MONOCLONAL HU1D10.GAMMA.(SUB 1)-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HU1D10 LIGHT CHAIN, DIMER
Common Name English
APOLIZUMAB [USAN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN HISTOCOMPATIBILITY ANTIGEN HLA-DR) (HUMAN-MOUSE MONOCLONAL HU1D10.GAMMA.(SUB 1)-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HU1D10 LIGHT CHAIN, DIMER. MOLECULAR WEIGHT IS APPROXIMATELY 150,000 DALTONS
Common Name English
HU-1D10
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN HISTOCOMPATIBILITY ANTIGEN HLA-DR) (HUMAN-MOUSE MONOCLONAL HU1D10.GAMMA.(SUB 1)-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HU1D10 LIGHT CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN HISTOCOMPATIBILITY ANTIGEN HLA-DR) (HUMAN-MOUSE MONOCLONAL HU1D10.GAMMA.(SUB 1)-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HU1D10 LIGHT CHAIN, DIMER. MOLECULAR WEIGHT IS APPROXIMATELY 150,000 DALTONS
Common Name English
apolizumab [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 00:21:49 GMT 2023 , Edited by admin on Sat Dec 16 00:21:49 GMT 2023
FDA ORPHAN DRUG 144701
Created by admin on Sat Dec 16 00:21:49 GMT 2023 , Edited by admin on Sat Dec 16 00:21:49 GMT 2023
Code System Code Type Description
CAS
267227-08-7
Created by admin on Sat Dec 16 00:21:49 GMT 2023 , Edited by admin on Sat Dec 16 00:21:49 GMT 2023
PRIMARY
ChEMBL
CHEMBL2108252
Created by admin on Sat Dec 16 00:21:49 GMT 2023 , Edited by admin on Sat Dec 16 00:21:49 GMT 2023
PRIMARY
WIKIPEDIA
APOLIZUMAB
Created by admin on Sat Dec 16 00:21:49 GMT 2023 , Edited by admin on Sat Dec 16 00:21:49 GMT 2023
PRIMARY
DRUG BANK
DB06467
Created by admin on Sat Dec 16 00:21:49 GMT 2023 , Edited by admin on Sat Dec 16 00:21:49 GMT 2023
PRIMARY
FDA UNII
G88KCP51RE
Created by admin on Sat Dec 16 00:21:49 GMT 2023 , Edited by admin on Sat Dec 16 00:21:49 GMT 2023
PRIMARY
INN
8210
Created by admin on Sat Dec 16 00:21:49 GMT 2023 , Edited by admin on Sat Dec 16 00:21:49 GMT 2023
PRIMARY
NCI_THESAURUS
C2228
Created by admin on Sat Dec 16 00:21:49 GMT 2023 , Edited by admin on Sat Dec 16 00:21:49 GMT 2023
PRIMARY
USAN
NN-26
Created by admin on Sat Dec 16 00:21:49 GMT 2023 , Edited by admin on Sat Dec 16 00:21:49 GMT 2023
PRIMARY
From To
1_22 1_95
1_143 1_199
1_219 3_214
1_225 2_225
1_228 2_228
1_260 1_320
1_366 1_424
2_22 2_95
2_143 2_199
2_219 4_214
2_260 2_320
2_366 2_424
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Related Record Type Details
APOLIZUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:SEQUENCE CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966